Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV businessPoint-of-Care product revenue ...

Investing.com -- Geopolitical tensions remain to the fore, while earnings and U.S. retail sales data will give an insight into the health of the consumer. Federal Reserve Chairman Jerome Powell is ...

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to ...

2371.TW Tatung Co., Ltd.

Among those that increased their exposure to the cryptocurrency was Israel Englander's Millennium, which more than doubled ...

Rapid7 Inc Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Stockholders To Reach Out ...

Providing a diverse range of perspectives from bullish to bearish, 20 analysts have published ratings on FedEx FDX in the ...

After years as an also-ran, My Little Pony was enshrined in the National Toy Hall of Fame on Tuesday along with Transformers ...

Wall Street stocks delivered a mixed performance on Wednesday as market participants digested fresh inflation data.

Landlords of rent-stabilized units are generally not able to increase the rent by more than what is allowed. But there are some exceptions. By Jill Terreri Ramos The New York City Council has ...